Table 5.
Linear regression models for the relationship between maternal race and ethnicity and percent of elevated glucoses when pharmacotherapy was initiated after excluding 44 women diagnosed with GDM in the first trimester
| Percent of abnormal blood glucose values prior to pharmacotherapy initiation | Adjusted linear regression coefficient (95% CI) | p-value |
|---|---|---|
| Race | ||
| Non-Hispanic White | Ref | |
| Non-Hispanic Black | 18.71 (11.63 – 25.79) | <0.001 |
| Hispanic | 11.64 (3.26 – 20.03) | 0.007 |
| Other | 8.53 (0.92 – 16.14) | 0.028 |
| Maternal age | −0.14 (−0.64 – 0.35) | 0.568 |
| Body mass index in early pregnancy(kg/m2) | 0.47 (0.18 – 0.76) | 0.001 |
| Marital Status | ||
| Single | Ref | |
| Married | −1.31 (−7.30 – 4.68) | 0.667 |
| Divorced | 7.27 (−6.97 – 21.51) | 0.316 |
| Insurance Status | ||
| Private | Ref | |
| Public | 7.26 (1.00 – 13.53) | 0.023 |
| None | −4.82 (−12.95 – 3.30) | 0.244 |
| Preexisting hypertension | ||
| No | Ref | |
| Yes | −2.74 (−15.50 – 10.02) | 0.673 |
| Gestational age at GDM diagnosis (wks) | 0.19 (−0.48 – 0.86) | 0.577 |
Bold indicates significant p-value